Biomerica, Inc.

05/29/2026

📣 Exciting news at Biomerica!

We've entered into a $1.75 million CDMO Master Services Agreement to develop proprietary in vitro diagnostic (IVD) assays for a confidential life sciences company.

Here's why it matters: it's our CDMO strategy in action. We're putting the same expertise behind our own diagnostics — more than 40 years of ELISA assay development, regulatory know-how, and FDA-licensed, ISO 13485-certified manufacturing — to work for outside partners, right here at our facility in Irvine, California.

Read the full announcement here: https://loom.ly/XFxNs4E

03/11/2026

⚠️ This Colorectal Cancer Awareness Month, there's an urgent message worth sharing with everyone you love:

Colorectal cancer is now the #1 cause of cancer deaths in adults under 50 — and according to Dr. Neil Parikh, Chief of Gastroenterology at Hartford Hospitals, it is "completely preventable."

In a recent Healio interview (source: https://loom.ly/xLwZmXk) Dr. Parikh broke down what's behind the alarming rise in younger patients: ultra-processed foods loaded with nitrates and preservatives, sedentary lifestyles, obesity, heavy alcohol use, and even emerging research pointing to microplastics as a potential contributor.

But here's the most important message: a colonoscopy doesn't just find cancer — it stops it before it starts. By removing precancerous polyps, you can change the entire trajectory of the disease.

Dr. Parikh also stressed that younger adults need to stop dismissing symptoms. Blood in the stool or persistent changes in bowel habits are not something to chalk up to hemorrhoids or food poisoning. If it's persistent, see a gastroenterologist.

Screening is now recommended starting at age 45. If you're approaching that age — or have a family history or symptoms — please don't wait.

The death of actor James Van Der Beek, diagnosed with stage III colorectal cancer at 46, is a heartbreaking reminder of what's at stake when warning signs go unaddressed.

Please share this post. Awareness saves lives. ❤️

Colorectal cancer is now the leading cause of cancer deaths among individuals aged younger than 50 years, and incidence continues to rise.

03/06/2026

New data reveals troubling trends: about 1 in 5 people diagnosed with colorectal cancer are now under 55, with incidence rising steadily among younger adults.

• Lifestyle factors like diet, inactivity, and processed foods may be contributing.
• Early diagnosis through screening is one of the strongest tools we have to reverse these trends.

👉 Share this post to help others understand why screening isn’t just for “older adults.”


Learn more: www.ezdetect.com

03/01/2026

March is Colorectal Cancer Awareness Month — a time to spotlight one of the most preventable but still deadly cancers worldwide. Each year, nearly 1.9 million people are diagnosed globally, with ~850,000 deaths — despite effective screening tools that can catch it early or even prevent it.

Screening matters — easy tests like stool-based kits and colonoscopy can find and remove precancerous polyps before they become cancer.

Let’s commit this month to share life-saving information — screening saves lives! 💙

02/27/2026

Great news for IBS patients! 🎉

We just released real-world data showing that nearly 60% of IBS patients experienced clinically meaningful abdominal pain relief — and over 68% saw significant bloating reduction — with the inFoods® IBS test.

Unlike medications that just mask symptoms, inFoods® IBS identifies your personal food triggers through a simple finger-stick blood test, so your doctor can recommend a diet tailored specifically to you.

Plus, Medicare now has a $300 national payment rate for the test, making it more accessible than ever.

Learn more at www.inFoodsibs.com 👉
Link to the full press release:
https://investors.biomerica.com/news/news-details/2026/Biomerica-Reports-Real-World-Data-Nearly-60-of-IBS-Patients-Achieved-Clinically-Meaningful-Pain-Reduction-and-68-Achieved-Bloating-Reduction-with-the-inFoods-IBS-Therapy/default.aspx

12/22/2025

As we wrap up the year, we want to thank our partners, customers, and friends for your continued support and collaboration.

Wishing you a happy holiday season and a successful year ahead.

🎄 Happy Holidays from the team at Biomerica 🎄

11/06/2025

Biomerica Expands CDMO Services to Meet Growing Market Demand

We are excited to announce the expansion of Biomerica’s Contract Development and Manufacturing Organization (CDMO) services to meet accelerating market demand. We are enhancing our capabilities to provide greater value of product development and manufacturing across the entire development lifecycle for diagnostic innovators worldwide.

Our expanded website now features a dedicated section highlighting our CDMO capabilities, making it easier for partners to explore our services, expertise, and collaborative solutions. Learn more about how Biomerica can help bring your diagnostic innovations to market faster and more efficiently.

Explore our CDMO Services: https://biomerica.com/contract-development-manufacturing/